BioSpace News Archive

Study designed to evaluate X4P-001-RD in a rare genetic, primary immunodeficiency disease to be presented at the American Society of Hematology meeting

Presentations will cover a wide range of blood diseases including multiple myeloma, lymphoma, chronic lymphocytic leukemia, acute myeloid leukemia, myelodysplastic syndromes and beta-thalassemia

New Orders, Production, and Employment Growing

The Charles Bronfman Prize announced its worldwide call for nominations for its 2019 Prize. The $100,000 annual award is presented to an individual or team whose innovative humanitarian work informed by Jewish values has significantly improved the world.

New Video Raises Awareness of Food Allergy as Serious Public Health Disease

Tricida, Inc. announced that it will report its third quarter 2018 financial results after the close of market on Thursday, November 8, 2018.

Nine abstracts accepted, including three oral presentations of ALXN1210 Phase 3 PNH data

TrovaGene, Inc. (NASDAQ: TROV), a clinical-stage oncology therapeutics company, taking a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, today announced that its abstract highlighting data from the Company’s lead clinical program in Acute Myeloid Leukemia (AML) has been accepted for presentation at the 60th American Society of Hematology (ASH) Annual Meeting, December 1-4, 2018.

Between October 15th and December 7th is the Time to be Open to Medicare Coverage Options for 2019

Organogenesis Inc. will celebrate the launch of the Advancing Healing Education Resource Center, a continuing medical education microsite covering the latest clinical and practical developments in wound healing, as well as showcase the company’s latest product research during the Symposium on Advanced Wound Care (SAWC) Fall 2018 meeting held this week in Las Vegas.